Ketoprofen
From Anvita Health Wiki
Contents |
Introduction
- Tradename: Orudis, Oruvail ( sustained-release).
Dosage
- 50-75 mg PO TID
- 200 mg PO QD ( sustained release)
- Tabs: 25, 50, 75 mg.
- Sustained-release: (Oruvail) 200 mg
Adverse-effects
Drug-interactions
-
- may divert metabolism to non- conjugated metabolites
- displace ketoprofen from plasma protein binding sites
- may inhibit conjugation of ketoprofen
- inhibits renal excretion of ketoprofen conjugates
- ketoprofen may inhibit renal excretion of:
- drug interaction(s) of lithium carbonate with NSAIDs
- drug interaction(s) of NSAIDs with SSRIs
- drug interaction(s) of aspirin with NSAIDs
- drug interaction(s) of NSAIDs with beta blockers
- drug interaction(s) of NSAIDs with ARBs
- drug interaction(s) of NSAIDs with ACE inhibitors
- drug interaction(s) of NSAIDs, diuretics & angiotensin II receptor antagonists
- drug interaction(s) of NSAIDs, diuretics & ACE inhibitors
- drug interaction(s) of NSAIDs & loop diuretics
- drug interaction(s) of NSAIDs & aspirin
More General Terms
Internet Database
PubChem: 3825
PubChem: 667550
PubChem: 42390
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Clinical Guide to Laboratory Tests, NW Tietz (ed) 3rd ed, WB Saunders, Philadelpha 1995
